GW-328267

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameGW-328267
Drug Alias NameGW-328267X328267GW-328267
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A2a receptor agonists
TargetsAdenosine A2a receptor
Therapy Area/IndicationsRhinitis, AllergicAcute Lung InjuryPulmonary Disease, Chronic Obstructive +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsRhinitis, AllergicAcute Lung InjuryPulmonary Disease, Chronic Obstructive +[4] 

Other Information

ATC CodeN/A
Related LinksN/A